Industry: Health care Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A biotechnology company in France, whose core specialty is to produce pharmaceutical-grade hyaluronic acid by fermentation, and develop a variety of biopolymer products on this basis. The company has a perfect R&D system and GMP production platform in line with international standards, and has the whole process capability from fermentation, purification to quality control. Its materials are widely used in medical beauty, ophthalmology, rheumatology, regenerative medicine and medicine. The company has a stable global layout, continuously expanding production capacity and investing in research and development of new biomaterials, and is an influential supplier of high-quality raw materials in the international market.
Enterprise products and services:
1. Pharmaceutical grade hyaluronic acid
Enterprises use fermentation technology to produce high-purity and traceable pharmaceutical-grade hyaluronic acid. Multi-molecular-weight specifications can be provided according to different purposes, and it is suitable for injection-type and high-end medical devices.
2. Research and development of biopolymers
On the basis of hyaluronic acid, a variety of biopolymers are developed, including nucleic acids, bio-based materials and functional derivatives. Provide customized material design and development services for medical, medical beauty and regenerative medicine enterprises.
3. Application support in medical field
Able to provide partners with research on material characteristics, legal support and application scenario matching suggestions. Covering medical beauty, ophthalmology, rheumatology, tissue repair and drug delivery.
Cooperation mode:
Seek partners who need hyaluronic acid and biomaterials services in the fields of medicine and beauty.